|
| Press Releases |
|
 |
|
| Thursday, June 29, 2023 |
|
|
BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development |
| BioMed X, a German independent research institute, announces the start of its first research project in collaboration with Sanofi: "Next Generation Virtual Patient Engine for Clinical Translation of Drug Candidates" (VPE). more info >> |
|
| Thursday, April 27, 2023 |
|
|
BioMed X Launches XSeed Labs in the US with Boehringer Ingelheim - a New Model for Building an External Innovation Ecosystem on an Industry Campus |
| BioMed X announced today the expansion of its collaboration with Boehringer Ingelheim with the launch of a new model for biomedical research: XSeed Labs. more info >> |
|
|
BioMed X Launches XSeed Labs in the US with Boehringer Ingelheim - a New Model for Building an External Innovation Ecosystem on an Industry Campus |
| BioMed X announced today the expansion of its collaboration with Boehringer Ingelheim with the launch of a new model for biomedical research: XSeed Labs. more info >> |
|
| Tuesday, April 4, 2023 |
|
|
BioMed X and Merck Expand Collaboration Aiming to Leverage Cancer-Specific Vulnerabilities for Targeted Therapies |
| BioMed X, an independent biomedical research institute, announces the start of its new research project - "New Strategies to Enhance the Immunogenicity of Tumors" - in collaboration with Merck. The focus of this new research group will be to develop novel approaches for enhancing tumor immunogenicity to broaden the population of patients who could benefit from cancer immunotherapy. more info >> |
|
|
BioMed X and Merck Expand Collaboration Aiming to Leverage Cancer-Specific Vulnerabilities for Targeted Therapies |
| BioMed X, an independent biomedical research institute, announces the start of its new research project - "New Strategies to Enhance the Immunogenicity of Tumors" - in collaboration with Merck. The focus of this new research group will be to develop novel approaches for enhancing tumor immunogenicity to broaden the population of patients who could benefit from cancer immunotherapy. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
AITO launches EV Road Tour from Chongqing to Jakarta
Aug 6, 2025 14:22 HKT/SGT
|
|
|
Robot Boom in HK: Shoucheng Holdings at the Forefront
Aug 6, 2025 13:40 HKT/SGT
|
|
|
University of Cyberjaya Welcomes Education Reforms under RMK13: A Bold Step Toward Future-Ready Talent and Inclusive Innovation
Aug 6, 2025 13:27: JST
|
|
|
University of Cyberjaya Welcomes Education Reforms under RMK13: A Bold Step Toward Future-Ready Talent and Inclusive Innovation
Aug 6, 2025 12:27 HKT/SGT
|
|
|
富士通、データドリブンで進めるHRBP活動による人的資本経営の実践をまとめた「CHRO Roundtable Report 2025」を発行
Aug 6, 2025 10:30: JST
|
|
|
Fujitsu's CHRO Roundtable Report 2025 highlights data-driven HRBP practices for human capital management
Aug 6, 2025 11:00 JST
|
|
|
AITO launches EV Road Tour from Chongqing to Jakarta
Aug 6, 2025 09:00: JST
|
|
|
TruMerit Launches Global Credential for First-Level, General Nurses
Aug 6, 2025 09:00 HKT/SGT
|
|
|
AI+儲能：範式集團與海博思創成立合資公司 市場前景廣闊
Aug 6, 2025 00:08 HKT/SGT
|
|
|
MHI Selected to Enter Next Stage Procurement Process for Australia's New General-Purpose Frigates
Aug 5, 2025 22:02 JST
|
|
|
三菱重工、豪州次期汎用フリゲートの共同開発・生産について発表
Aug 5, 2025 15:00: JST
|
|
|
AI+储能：范式集团与海博思创成立合资公司 市场前景广阔
Aug 5, 2025 14:50 HKT/SGT
|
|
|
港股機器人板塊升溫 首程控股領跑前線
Aug 5, 2025 14:32 HKT/SGT
|
|
|
港股机器人板块升温 首程控股领跑前线
Aug 5, 2025 14:32 HKT/SGT
|
|
|
Atlas Lithium 的 Neves 项目完成最终可行性研究，预估内部报酬率为 145%，回本期为 11 个月
Aug 5, 2025 13:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
